Ajanta Pharma Limited Buyback
Ajanta Pharma Buyback 2024
Tender Offer
₹2,770.00
Buyback price per share29 May, 2024
Last Date to buy shares30 May, 2024
Record Date05 Jun, 2024
Offer Opens11 Jun, 2024
Offer Closes11 Jun, 2024
Last Date for Tender Forms18 Jun, 2024
Finalisation of Buyback Acceptance19 Jun, 2024
Last Date for settlement of bids28 Jun, 2024
Last Date for Extinguishment of SharesAbout Ajanta Pharma Limited Buyback Company
Ajanta Pharma Limited develops, manufactures and markets specialty pharmaceutical formulations.
The Company has seven manufacturing facilities in India , two of which have been approved by the US FDA. Additionally, the Company has a research and development centre for active pharmaceutical ingredient synthesis and finished formulations.
The company does business in three areas:
Branded Generics in India and emerging markets in Asia and Africa
Generics in the USA
Institutional sales in Africa.
The company supplies its products to more than 30 countries.
Ajanta Pharma employs over 7,700 people from more than 30 countries worldwide.
Ajanta Pharma Limited Buyback Details
- Security Name Ajanta Pharma Limited
- Buyback Price ₹2,770.00
- Face Valuet ₹2.00
- Listing at Group BSE,NSE
- Lead Manager Vivro Financial Services Private Limited
- Issue Size 1,028,881 (0.82 % of Total number of equity Shares)
- Buyback Docs Letter Of Offer
Ajanta Pharma Limited Buyback Ratio
| Categoryy | Entitlement Ratio of Buyback | Shares Offered |
|---|---|---|
| Reserved Category for Small Shareholders | 1/8 | 154333 |
| General Category for all other Eligible Shareholders | 1/128 | 874548 |
Ajanta Pharma Limited Buyback Company Financials
| 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|
| Total Revenue | 4,293.31 | 3,841.28 | -- |
| Reserves And Surplus | -- | -- | -- |
| Total Borrowing | -- | -- | -- |
| Net Worth | -- | -- | -- |
| Profit After Tax | 816.17 | 587.98 | -- |
| Total Assets | 4,638.39 | 4,679.02 | -- |
How to Participate in Ajanta Pharma Limited Buyback?
Calculation of Investment in Ajanta Pharma Limited Buyback Buyback 2026
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date May 2, 2024
Expected Profit from the Ajanta Pharma Limited Buyback on the bases of acceptance Ratio:
| Acceptance Ratio | Amount Invested in Buyback | No. of Shares Buyback | Buyback Profit | Profit% |
|---|---|---|---|---|
| 33% | ₹161,234.66 | 23 | 12348 | 7.66% |
| 50% | ₹161,234.66 | 36 | 19328 | 11.99% |
| 75% | ₹161,234.66 | 54 | 28992 | 17.98% |
| 100% | ₹161,234.66 | 72 | 38656 | 23.97% |
Amount Invested in Buyback: ₹161,234.66
Ajanta Pharma Limited Buyback - Necessity of the Objective
The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
The Buyback, which is being implemented through the tender offer route as prescribed under the SEBI Buyback Regulations, would involve the allocation of the number of Equity Shares as per their entitlement or 15% of the number of Equity Shares to be bought back whichever is higher, reserved for the small shareholders. The Company believes that this reservation for small shareholders would benefit a large number of public shareholders, who would be classified as small shareholders as per Regulation 2(i)(n) of the SEBI Buyback Regulations;
The Buyback may help in improving its earnings per share and return on equity, by reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer, without additional investment.
Contact Details
Ajanta Pharma Limited Buyback
Ajanta House’, 98 Govt Industrial Area, Charkop, Kandivli (West), Mumbai - 400 067
+91 22 6606 1000
investorgrievance@ajantapharma.com
Registrar Contact Details
Link Intime India Private Ltd
ajantapharma2024.buyback@linkintime.co.in
+91-22-4918 6270